The engagement of TIGIT by NECTIN3 on tumor cells results in the functional impairment of both T cell subsets, thereby reducing their ability to mount an effective anti-tumor response and promoting tumor immune evasion. The gene discussed is NECTIN3; the disease is neoplasm.